Personalized prediction of EGFR mutation-induced drug resistance in lung cancer

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Wang, Debby D ^a   Zhou, Weiqiang ^a   Yan, Hong ^a   Wong, Maria ^b   Lee, Victor ^b  

^a CITY UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN KINASE INHIBITOR;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; DRUG ANTAGONISM; DRUG RESISTANCE; DRUG STABILITY; FEMALE; GENETICS; HUMAN; LUNG TUMOR; MALE; MOLECULAR DOCKING; MOLECULAR DYNAMICS; MUTATION; PERSONALIZED MEDICINE; PROTEIN BINDING; RISK FACTOR;

ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, NEOPLASM; DRUG STABILITY; FEMALE; HUMANS; INDIVIDUALIZED MEDICINE; LUNG NEOPLASMS; MALE; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MOLECULAR DOCKING SIMULATION; MOLECULAR DYNAMICS SIMULATION; MUTATION; PROTEIN BINDING; PROTEIN KINASE INHIBITORS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RISK FACTORS;

EID: 84885093996     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep02855     Document Type: Article

References (39)

1. Lynch, T. J. et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-Small-Cell lung cancer to gefitinib. NEngl JMed 350, 2129-2139 (2004).
2. Yun, C. H. et al. The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP. Proc Natl Acad Sci U S A 105, 2070-2075 (2008).
3. Zhang, Z. F. et al. Activation of the AXL kinase causes resistance to EGFR-Targeted therapy in lung cancer. Nat Genet 44, 852-60 (2012).
4. Hou, T. J., Zhang, W.,Wang, J.&Wang, W. Predicting drug resistance of the HIV-1 protease using molecular interaction energy components. Proteins 74, 837-846 (2009).
5. Kobayashi, S. et al. EGFR mutation and resistance of non-Small-Cell lung cancer to gefitinib. New Engl J Med 352, 786-792 (2005).
6. Kwak, E. L. et al. Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib. P Natl Acad Sci USA 102, 7665-7670 (2005).
7. Pao, W. et al.Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. Plos Med 2, 225-235 (2005).
8. Carter, T. A. et al. Inhibition of drug-Resistant mutants of ABL, KIT, and EGF receptor kinases. P Natl Acad Sci USA 102, 11011-11016 (2005).
9. Greulich, H. et al. Oncogenic transformation by inhibitor-Sensitive and-Resistant EGFR mutants. Plos Med 2, 1167-1176 (2005).
10. Sequist, L. V. Second-Generation epidermal growth factor receptor tyrosine kinase inhibitors in non-Small cell lung cancer. Oncologist 12, 325-330 (2007).
11. Cao, Z. W. et al. Computer prediction of drug resistance mutations in proteins. Drug Discov Today 10, 521-529 (2005).
12. Hao, G. F., Yang, G. F. & Zhan, C. G. Structure-Based methods for predicting target mutation-Induced drug resistance and rational drug design to overcome the problem. Drug Discov Today 17, 1121-1126 (2012).
13. Sneddon, M. W. & Emonet, T. Modeling cellular signaling: Taking space into the computation. Nat Methods 9, 239-242 (2012).
14. Cohen, A. R., Gomes, F. L., Roysam, B.&Cayouette, M. Computational prediction of neural progenitor cell fates. Nat Methods 7, 213-218 (2010).
15. Loo, L. H.,Wu, L. F. & Altschuler, S. J. Image-Based multivariate profiling of drug responses from single cells. Nat Methods 4, 445-453 (2007).
16. Berman, H. M. et al. The Protein Data Bank. Nucleic Acids Res 28, 235-242 (2000).
17. Draghici, S. & Potter, R. B. Predicting HIV drug resistance with neural networks. Bioinformatics 19, 98-107 (2003).
18. Wang, D. C. & Larder, B. Enhanced prediction of lopinavir resistance from genotype by use of artificial neural networks. J Infect Dis 188, 653-660 (2003).
19. Larsen, P. E., Field, D.&Gilbert, J. A. Predicting bacterial community assemblages using an artificial neural network approach. Nat Methods 9, 621-625 (2012).
20. Beerenwinkel, N. et al. Geno2pheno: Estimating phenotypic drug resistance from HIV-1 genotypes. Nucleic Acids Res 31, 3850-3855 (2003).
21. Beerenwinkel, N. et al. Diversity and complexity of HIV-1 drug resistance: A bioinformatics approach to predicting phenotype from genotype. Proc Natl Acad Sci U S A 99, 8271-8276 (2002).
22. Xiang, Z. X.&Honig, B. Extending the accuracy limits of prediction for side-Chain conformations. J Mol Biol 311, 421-430 (2001).
23. Xiang, Z., Soto, C. S. & Honig, B. Evaluating conformational free energies: The colony energy and its application to the problem of loop prediction. Proc Natl Acad Sci U S A 99, 7432-7437 (2002).
24. Case, D. A. et al. AMBER 12, University of California, San Francisco (2012).
25. Huang, G. B., Wang, D. H. & Lan, Y. Extreme learning machines: A survey. International Journal of Machine Learning and Cybernetics 2, 107-122 (2011).
26. Huang, G. B., Zhu, Q. Y. & Siew, C. K. Extreme learning machine: Theory and applications. Neurocomputing 70, 489-501 (2006).
27. Jakalian, A., Jack, D. B. & Bayly, C. I. Fast, efficient generation of high-Quality atomic charges. AM1-BCC model: II. Parameterization and validation. J Comput Chem 23, 1623-1641 (2002).
28. Ponder, J. W. & Richards, F. M. Tertiary Templates for Proteins-Use of Packing Criteria in the Enumeration of Allowed Sequences for Different Structural Classes. J Mol Biol 193, 775-791 (1987).
29. Soto, C. S., Fasnacht, M., Zhu, J., Forrest, L.&Honig, B. Loop modeling: Sampling, filtering, and scoring. Proteins 70, 834-843 (2008).
30. Shenkin, P. S., Yarmush, D. L., Fine, R. M.,Wang, H. J. & Levinthal, C. Predicting antibody hypervariable loop conformation. I. Ensembles of random conformations for ringlike structures. Biopolymers 26, 2053-2085 (1987).
31. Pettersen, E. F. et al. UCSF chimera-A visualization system for exploratory research and analysis. Journal of Computational Chemistry 25, 1605-1612 (2004).
32. Wang, Q. T. & Bryce, R. A. Improved Hydrogen Bonding at the NDDO-Type Semiempirical Quantum Mechanical/Molecular Mechanical Interface. J Chem Theory Comput 5, 2206-2211 (2009).
33. Palau, J., Argos, P. & Puigdomenech, P. Protein secondary structure. Studies on the limits of prediction accuracy. Int J Pept Protein Res 19, 394-401 (1982).
34. Cavasotto, C. N. & Phatak, S. S. Homology modeling in drug discovery: Current trends and applications. Drug Discov Today 14, 676-683 (2009).
35. Vyas, V. K., Ukawala, R. D., Ghate, M. & Chintha, C. Homology Modeling a Fast Tool for Drug Discovery: Current Perspectives. Indian J Pharm Sci 74, 1-17 (2012).
36. Bolz, J., Farmer, I., Grinspun, E. & Schroder, P. Sparse matrix solvers on the GPU: Conjugate gradients and multigrid. Acm T Graphic 22, 917-924 (2003).
37. Kruger, J. &Westermann, R. Linear algebra operators for GPU implementation of numerical algorithms. Acm T Graphic 22, 908-916 (2003).
38. Owens, J. D. et al. GPU computing. P Ieee 96, 879-899 (2008).
39. Ryoo, S. et al. Program optimization carving for GPU computing. J Parallel Distr Com 68, 1389-1401 (2008).